Advertisement
Case Report| Volume 53, ISSUE 1, e4-e6, February 2018

A rare case of bilateral ocular neuromyotonia

      Unilateral ocular neuromyotonia (ONM) is a rare entity, and bilateral ONM even more so, with and only 1 case having been reported previously in the literature. We present a rare case of bilateral ocular neuromyotonia whose course of treatment was complicated by side effects of carbamazepine.

      Case Report

      A 35-year-old female was referred by her oncologist with a 12-month history of blurring that was most noticeable on right lateral gaze. During the episodes of blurring, she felt a tugging sensation that could last for up to 1 minute. These episodes had become more frequent over the past 6 months, increasing to 6 to 7 times per day. Notable medical history included nasopharyngeal cancer (NPC), which was treated with 4 cycles of cisplatin and 5-fluorouracil (5FU) and concurrent daily radiotherapy for 6.5 weeks, 8 years prior. One month after completing her treatment, she experienced paraesthesia in her left lower face, neck, and left arm. Investigation of this led to a diagnosis of hypopituitarism and hypothyroidism, well controlled with growth hormone injections and thyroxine. Four years later, she experienced dysphagia, which was attributed to late deterioration from radiotherapy-induced damage. Her dysphagia caused significant weight loss, and she was referred for a feeding tube.
      On examination, best-corrected visual acuity was –0.15 logMAR bilaterally. At rest, there was a stable near exophoria of 4 prism diopters. In primary position, the patient was orthophoric. After sustained gaze to the right, the divergent deviation increased to 25 prism diopters. After sustained gaze to the left, the divergent deviation increased to a lesser extent by 16 prism diopters. Following prolonged gaze testing, she was noted to have reduced adduction of the right eye with left abducting nystagmus. She also was noted to have reduced adduction of the left eye. Horizontal eye movements are demonstrated in Fig. 1. After sustained upgaze, she consistently showed upper lid lag in depressed positions (bilateral pseudo von Graefe sign) and a depression deficit in the left eye (Fig. 2). There was no anisocoria, and both pupils were reactive to light and accommodation.
      Fig. 1
      Fig. 1Horizontal eye movements. Direction of gaze indicated on image by arrow or stated as being in primary position (1°). (A) Right gaze: no abnormality seen; (B) primary position: no abnormality seen; (C) left gaze: no abnormality seen; (D) right gaze after sustained left gaze: left exotropia; (E) primary position after sustained left gaze: left exotropia; (F) sustained left gaze: no abnormality seen; (G) sustained right gaze: no abnormality seen; (H) primary position after sustained right gaze: right exotropia; and (I) left gaze after sustained right gaze: right exotropia.
      Fig. 2
      Fig. 2Vertical eye movements. Direction of gaze indicated on image by arrow or stated as being in primary position (1°). (A) Primary position: no abnormality seen; (B) left lid lag on down gaze; (C) downgaze after sustained upgaze: left levator and SR myotonia; and (D) primary position.
      Anterior segment intraocular pressures and fundus examination were unremarkable. Investigations included serology, electromyography (EMG), and magnetic resonance imaging (MRI). Serology, including acetylcholine receptor antibodies, was unremarkable. The divergent position of the eyes was noted during the short tau inversion recovery sequence of the MRI. Repetitive stimulation EMG and single-fibre EMG were normal. Findings were consistent with bilateral ocular neuromyotonia, and treatment with carbamazepine 200 mg twice a day was initiated.
      She responded well to treatment, and her symptoms resolved after 1 week. However, she developed a widespread itchy skin rash. Her treatment was reduced to 100 mg twice daily, her rash resolved, and her symptoms remained controlled.

      Discussion

      ONM is a rare clinical entity, characterized by episodic involuntary contraction of ≥1 extraocular muscles.
      • Roper-Hall G.
      • Chung S.M.
      • Cruz O.A.
      Ocular neuromyotonia: differential diagnosis and treatment.
      • Plant G.T.
      Putting ocular neuromyotonia in context.
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      The most common cranial nerve affected is the oculomotor nerve,
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      followed by the trochlear and abducens nerves.
      • Choi K.D.
      • Hwang J.M.
      • Park S.H.
      • Kim J.S.
      Primary aberrant regeneration and neuromyotonia of the third cranial nerve.
      There is no preponderance for either sex.
      • Roper-Hall G.
      • Chung S.M.
      • Cruz O.A.
      Ocular neuromyotonia: differential diagnosis and treatment.
      To our knowledge, ONM has been reported to be bilateral in only 1 other case in the literature.
      • Morrow M.J.
      • Kao G.W.
      • Arnold A.C.
      Bilateral ocular neuromyotonia: oculographic correlations.
      The spasmodic neuronal dischargers in ONM result in deviation of the affected eye accompanied by diplopia.
      • de Saint Sardos A.
      • Vincent A.
      • Aroichane M.
      • Ospina L.H.
      Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
      Symptoms can occur spontaneously but are usually elicited after a period of prolonged gaze in the direction of the affected muscle.
      • Roper-Hall G.
      • Chung S.M.
      • Cruz O.A.
      Ocular neuromyotonia: differential diagnosis and treatment.
      Length of episodes can vary from seconds to several minutes.
      • Roper-Hall G.
      • Chung S.M.
      • Cruz O.A.
      Ocular neuromyotonia: differential diagnosis and treatment.
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      • de Saint Sardos A.
      • Vincent A.
      • Aroichane M.
      • Ospina L.H.
      Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
      The pathophysiology behind the aberrant firing of the affected neurons is still debated but is thought to be linked to unstable neuronal membranes, especially in view of its successful treatment with membrane-stabilizing medications.
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      • de Saint Sardos A.
      • Vincent A.
      • Aroichane M.
      • Ospina L.H.
      Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
      As in the case presented here, ONM often is associated with radiation therapy (≤60% of cases) and can present as late as 18 years after treatment.
      • Roper-Hall G.
      • Chung S.M.
      • Cruz O.A.
      Ocular neuromyotonia: differential diagnosis and treatment.
      • Plant G.T.
      Putting ocular neuromyotonia in context.
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      • de Saint Sardos A.
      • Vincent A.
      • Aroichane M.
      • Ospina L.H.
      Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
      • Giardina A.S.
      • Slagle W.S.
      • Greene A.M.
      • Musick A.N.
      • Eckermann D.R.
      Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review.
      Of particular note is the suggestion by Kau et al that cisplatin and 5FU, which were used in the present case, are known to cause cranial nerve toxicity. It was hypothesized this may increase sensitivity to radiation and increase the chance of developing ONM.
      • Kau H.C.
      • Tsai C.C.
      Abducens ocular neuromyotonia in a patient with nasopharyngeal carcinoma following concurrent chemoradiotherapy.
      Differential diagnosis of ONM includes ocular myasthenia gravis, demyelination, cyclic oculomotor paresis, superior oblique myokymia, cyclic oculomotor paresis, and Graves’ disease.
      • Lee K.
      • Aui-Aree N.
      • DP A.
      A 54 year old man with intermittent diplopia.
      Appropriate serologic and EMG testing should be undertaken. Imaging is imperative to exclude any space-occupying legion,
      • Salchow D.J.
      • Wermund T.K.
      Abducens neuromyotonia as the presenting sign of an intracranial tumor.
      • de Saint Sardos A.
      • Vincent A.
      • Aroichane M.
      • Ospina L.H.
      Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
      particularly in those patients with a history of nasopharyngeal cancer (NPC), as NPC is associated with cranial nerve palsy in nearly 25% of cases.
      • Kau H.C.
      • Tsai C.C.
      Abducens ocular neuromyotonia in a patient with nasopharyngeal carcinoma following concurrent chemoradiotherapy.
      Management includes treatment with carbamazepine, with dosage varying from 100 to 600 mg.
      • Giardina A.S.
      • Slagle W.S.
      • Greene A.M.
      • Musick A.N.
      • Eckermann D.R.
      Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review.
      A good response has been reported, with 87.8% responding to this treatment.
      • Giardina A.S.
      • Slagle W.S.
      • Greene A.M.
      • Musick A.N.
      • Eckermann D.R.
      Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review.
      However, as demonstrated with the present case, side effects may complicate management.

      Disclosure

      The authors have no proprietary or commercial interest in any materials discussed in this article.

      References

        • Roper-Hall G.
        • Chung S.M.
        • Cruz O.A.
        Ocular neuromyotonia: differential diagnosis and treatment.
        Strabismus. 2013; 21: 131-136
        • Plant G.T.
        Putting ocular neuromyotonia in context.
        J Neuroophthalmol. 2006; 26: 241-243
        • Salchow D.J.
        • Wermund T.K.
        Abducens neuromyotonia as the presenting sign of an intracranial tumor.
        J Neuroophthalmol. 2011; 31: 34-37
        • Choi K.D.
        • Hwang J.M.
        • Park S.H.
        • Kim J.S.
        Primary aberrant regeneration and neuromyotonia of the third cranial nerve.
        J Neuroophthalmol. 2006; 26: 248-250
        • Morrow M.J.
        • Kao G.W.
        • Arnold A.C.
        Bilateral ocular neuromyotonia: oculographic correlations.
        Neurology. 1996; 46: 264-266
        • de Saint Sardos A.
        • Vincent A.
        • Aroichane M.
        • Ospina L.H.
        Ocular neuromyotonia in a 15-year-old girl after radiation therapy.
        J AAPOS. 2008; 12: 616-617
        • Giardina A.S.
        • Slagle W.S.
        • Greene A.M.
        • Musick A.N.
        • Eckermann D.R.
        Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review.
        Optom Vis Sci. 2012; 89: e124-e134
        • Kau H.C.
        • Tsai C.C.
        Abducens ocular neuromyotonia in a patient with nasopharyngeal carcinoma following concurrent chemoradiotherapy.
        J Neuroophthalmol. 2010; 30: 266-267
        • Lee K.
        • Aui-Aree N.
        • DP A.
        A 54 year old man with intermittent diplopia.
        Digit J Ophthalmol. 2005; : 11